|
Category :
Company News
Headline :
Biocon - Press Release
Date:
17/04/2024 18:30
Biocon Limited has informed the Exchange regarding a press release dated April 17, 2024, titled ""Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A."".
|